Who We Are

Using automated chemical synthesis technologies licensed from SRI International, the Synfini platform boasts the world’s first AI “Large Chemistry Model”, a multi-scale, robotic data generation system, and a vast AI chemistry dataset.

Who We Are

Synfini is at the forefront of AI-driven drug discovery. Our platform seamlessly integrates advanced AI models, automated workflows, and robust analytics to help researchers achieve optimized drug candidates faster, smarter, and more cost-effectively. Backed by years of expertise in chemistry and machine learning, we are your trusted partner in the journey from target to candidate.

Our Mission & Vision

Our mission is to dramatically reduce the time and cost of translating hits, targets and virtual drug concepts to validated candidates. We will enable our industry partners to create over a thousand new drug candidates over the next 10 years.
We are focused on leading the innovative change in drug discovery and development that will improve lives worldwide.

Meet Our Leadership Team

Doug Donzelli

CEO

Doug is a serial entrepreneur and CEO with over 40 years of experience in technology. Doug’s domain and technology experience includes healthcare, medical devices, industrial process chemistry, and software development.

Peter Madrid, PhD

Scientific Development

Peter brings over 17 years of leadership experience in transformative chemistry and automation technologies and joined the Synfini team after his tenure at SRI Biosciences. Peter’s career has been focused on developing new therapeutics and diagnostics for infectious diseases with unmet medical needs.

Nathan Collins, PhD

Strategic Alliances

Nathan is an experienced biotech executive with 25 plus years in the drug discovery industry. He was the Chief Strategy Officer at SRI Biosciences and is the Synfini visionary. Nathan has a strong background in managing drug, diagnostic and technology pipelines from target identification through clinical development.

Elizabeth Miyagi

Finance

Liz leads finance for Synfini. She is an experienced finance executive with over 30
years of startup financial management and fundraising support.

Synfini’s Mission & Vision​

Our mission is to dramatically reduce the time and cost of translating hits, targets and virtual drug concepts to validated candidates. We will enable our industry partners to create over a thousand new drug candidates over the next 10 years.​

We are focused on leading the innovative change in drug discovery and ​ development that will improve lives worldwide

Ready to Accelerate Your Drug Discovery Journey?

Don’t let bottlenecks slow your progress. Synfini AI Cloud Foundry offers the tools and expertise to accelerate your drug discovery process like never before. Let’s work together to optimize your path to breakthrough innovations. Contact us today and take the first step toward success!

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.